| |  | To close out 2022, First Opinion presented the most-read essays of the year, published its first operetta, and more. Now it's time to ring in the New Year! May 2023 be a fruitful and fulfilling year for you. | | | | By Patrick Skerrett Hyacinth Empinado STAT published nearly 500 First Opinion essays in 2022. All are worth reading, or rereading. You can see the 5 most-read essays here. Read More | | By Peter J. Pitts Alex Hogan/STAT With apologies to Gilbert & Sullivan, here's a little list (modeled on a song from "The Mikado") about the FDA's approval of Aduhelm. Read More | | Sponsored Insight by STAT+ Searching for the perfect gift? Get 3 months of STAT+ for $30. A STAT+ subscription gives you unlimited access to in-depth investigative journalism, groundbreaking analysis, subscriber-only newsletters, and industry event discounts. With a premium membership, you’ll get your life sciences news direct from the source. For a limited time only, get three months of STAT+ for just $30. Subscribe now. | | By Andrew Dreyfus Adobe In Massachusetts, a value-based payment model that rewards clinicians for closing equity gaps can be a model for the nation. Read More | | By Robert Gabbay Adobe People with obesity shouldn't have to wait until they develop diabetes or other illness before Medicare covers obesity medication. Read More | |
No comments